← Back to Search

Starting the Conversation for Gynecologic Cancers

N/A
Waitlist Available
Research Sponsored by Fox Chase Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

Study Summary

The central goal of this randomized, controlled pilot study is to examine the feasibility, acceptability, and preliminary effects of an educational intervention (called "Starting the Conversation"; STC) on patient communication about sexual health in gynecologic cancer and other patient health outcomes. Approximately 30 women with a diagnosis of gynecologic cancer will be randomized to either participate in either the Starting the Conversation (STC) condition, consisting of an educational video, workbook, and list of resources on sexual and menopausal health, or to a control condition offering the resource guide only. Patients will be asked to review intervention materials prior to their next clinic visit with their gynecologic cancer provider. The investigators will examine effects of the interventions on patients' beliefs about communication about sexual health and on patients' communication about sexual health during clinic visits with their providers. Secondarily, the investigators will examine effects of the interventions on sexual outcomes and other health outcomes, including psychological well-being.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Feasibility - Enrollment
Feasibility - Intervention Completion
+1 more
Secondary outcome measures
Clinical Communication - Asking a Question About Sexual Health
Clinical Communication - Discussion of Sexual Health
Clinical Communication - Raising Topic of Sexual Health
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Starting the ConversationExperimental Treatment2 Interventions
Participants are asked to watch an educational video along with an accompanying workbook (called "Starting the Conversation"). Participants are also asked to review a list of resources about sexual and menopausal health relevant to gynecologic cancer.
Group II: Sexual and Menopausal Health Resources OnlyActive Control1 Intervention
Participants are given the list of resources about sexual and menopausal health only.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sexual and Menopausal Health Resources Only
2022
N/A
~40
Starting the Conversation
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Fox Chase Cancer CenterLead Sponsor
227 Previous Clinical Trials
37,506 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025